For example, C2-ceramide reprograms tumor-associated macrophages toward an M1 phenotype through protein kinase Cζ-dependent mechanisms, enhancing pro-inflammatory cytokine secretion and improving CD8+ T cell cytotoxicity within the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.